Annals of Indian Academy of Neurology
ORIGINAL ARTICLE
Year
: 2022  |  Volume : 25  |  Issue : 3  |  Page : 401--406

Impact of antecedent infections on the antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: A correlative study


Debprasad Dutta1, Monojit Debnath1, Doniparthi V Seshagiri2, Binu V Sreekumaran Nair3, Sumit K Das3, Rahul Wahatule2, Sanjib Sinha2, Vasanthapuram Ravi4, Arun B Taly2, Madhu Nagappa2 
1 Department of Human Genetics, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, India
2 Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, India
3 Department of Biostatistics, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, India
4 Department of Neurovirology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, India

Correspondence Address:
Madhu Nagappa
Additional Professor, Department of Neurology, National Institute of Mental Health & Neurosciences (NIMHANS), Hosur Road, Bengaluru - 560 029, Karnataka
India

Background and Aims: Guillain-Barré Syndrome (GBS), an immune-mediated neuropathy, is characterized by antibodies against gangliosides/ganglioside complexes (GSCs) of peripheral nerves. Antecedent infections have been reported to induce antibodies that cross-react with the host gangliosides and thereby have a pivotal role in conferring an increased risk for developing GBS. Data pertaining to the impact of various antecedent infections, particularly those prevalent in tropical countries like India on the ganglioside/GSC antibodies is sparse. We aimed at exploring the association between six antecedent infections and the profile of ganglioside/GSC antibodies in GBS. Methods: Patients with GBS (n = 150) and healthy controls (n = 50) were examined for the serum profile of antibodies against GM1, GM2, GD1a, GD1b, GT1b, and GQ1b and their GSCs by ELISA. These antibodies were correlated with immunoreactivities against Campylobacter jejuni, Japanese encephalitis (JE), dengue, influenza, zika, and chikungunya infections. Results: The frequencies of antibodies against six single gangliosides (P < 0.001) and their GSCs (P = 0.039) were significantly higher in patients as compared to controls. Except for GT1b-antibody which was more frequent in axonal GBS, none of the other ganglioside/GSC antibodies correlated with the electrophysiological subtypes of GBS. Antecedent JE infection was significantly associated with increased frequency of antibodies against GD1a, GD1b, GT1b, and GQ1b. Antibodies against GSCs were not influenced by the antecedent infections. Interpretation: This study for the first time shows an association between antecedent JE infection and ganglioside antibodies in GBS. This finding reinforces the determining role of antecedent infections on ganglioside antibody responses and the subsequent immunological processes in GBS.


How to cite this article:
Dutta D, Debnath M, Seshagiri DV, Sreekumaran Nair BV, Das SK, Wahatule R, Sinha S, Ravi V, Taly AB, Nagappa M. Impact of antecedent infections on the antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: A correlative study.Ann Indian Acad Neurol 2022;25:401-406


How to cite this URL:
Dutta D, Debnath M, Seshagiri DV, Sreekumaran Nair BV, Das SK, Wahatule R, Sinha S, Ravi V, Taly AB, Nagappa M. Impact of antecedent infections on the antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: A correlative study. Ann Indian Acad Neurol [serial online] 2022 [cited 2022 Sep 27 ];25:401-406
Available from: https://www.annalsofian.org/article.asp?issn=0972-2327;year=2022;volume=25;issue=3;spage=401;epage=406;aulast=Dutta;type=0